Holen Sie sich die Stockscreener-App
1.19
5.31%
0.06
Handel nachbörslich:
1.19
Schlusskurs vom Vortag:
$1.13
Offen:
$1.14
24-Stunden-Volumen:
584.52K
Relative Volume:
0.71
Marktkapitalisierung:
$156.01M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1019
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
+9.17%
1M Leistung:
+15.53%
6M Leistung:
+14.42%
1J Leistung:
+32.25%
1-Tages-Spanne:
$1.13
$1.19
1-Wochen-Bereich:
$1.07
$1.19
52-Wochen-Spanne:
$0.80
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.19 | 148.14M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.77 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.83 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - marketscreener.com
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed Announces Reverse Stock Split - marketscreener.com
PAVmed Announces Reverse Stock Split - Benzinga
Ideas Watch: Will Lucid Diagnostics Inc stock see PE expansionWeekly Investment Summary & AI Driven Stock Price Forecasts - moha.gov.vn
Bull Run: Why Lucid Diagnostics Inc stock remains on buy listsJuly 2025 Gainers & Community Verified Trade Signals - moha.gov.vn
Here’s Why Lucid Diagnostics (LUCD) Declined in Q3 - Insider Monkey
Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN
With Lucid Diagnostics Stock Surging, Have You Considered The Downside? - Trefis
Can Lucid Diagnostics Inc. stock reach $100 price targetJuly 2025 Momentum & Comprehensive Market Scan Reports - Улправда
What valuation multiples suggest for Lucid Diagnostics Inc. stockJuly 2025 WrapUp & Smart Allocation Stock Tips - DonanımHaber
Can Lucid Diagnostics Inc. stock rebound after recent weakness2025 Trade Ideas & Free Safe Capital Growth Stock Tips - DonanımHaber
How analysts rate Lucid Diagnostics Inc. stock todayInflation Watch & Consistent Return Strategy Ideas - DonanımHaber
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) Price Target at $3.94 - Defense World
Lucid Group stock hits 52-week low at $11.46 - Investing.com
Lucid Diagnostics Earnings Notes - Trefis
Can Lucid Diagnostics Inc stock rebound after recent weakness2025 Top Decliners & Verified Momentum Stock Ideas - moha.gov.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Lucid Diagnostics (NASDAQ:LUCD) Using Too Much Debt? - simplywall.st
Ascendiant Capital Markets Issues Positive Forecast for Lucid Diagnostics (NASDAQ:LUCD) Stock Price - Defense World
Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative
Lucid Diagnostics (NASDAQ:LUCD) Given New $8.25 Price Target at Ascendiant Capital Markets - MarketBeat
LUCD FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital By Investing.com - Investing.com South Africa
Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital - Investing.com Canada
Lucid Diagnostics files $175M mixed securities shelf - MSN
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics (LUCD) Stock: Surge After Real-World EsoGuard Data Breakthrough! - parameter.io
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
Lucid Diagnostics (Nasdaq: LUCD) reports 95% EsoCheck success in 11,991 patients - Stock Titan
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
A Look at Lucid Diagnostics Inc (LUCD) Shares in the Recent Past Indicates Growth - Setenews
Should I hold or sell Lucid Diagnostics Inc. stock in 2025Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser
Is Lucid Diagnostics, Inc. overvalued or undervalued? - Markets Mojo
Why Lucid Diagnostics Inc. stock appeals to analysts2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser
Lucid Diagnostics (LUCD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance
Is Lucid Diagnostics Inc (LUCD) positioned for future growth? - Setenews
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
Get in on Lucid Diagnostics Inc’s (LUCD) buy-in window today! - Setenews
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada
Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com
Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lucid Diagnostics Inc-Aktie (LUCD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
1.64%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):